Recruiting

Observational Study

Sponsor:

Methodist Health System

Code:

NCT07490145

Conditions

Trauma

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

over- and under-triage rates

Study Details

Brief summary:

To quantify the over- and under-triage rates as relative to trauma activation criteria reform.

Conditions

Trauma

Study ID

NCT07490145

Start date

Nov 24, 2024

Status verified date

Feb, 2026

Completion date

Nov, 2028

Anticipated

Primary completion date

Nov 24, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

Patient is included in the Methodist Dallas Medical Center trauma registry. Trauma patients who recieved care at Methodist Dallas Medical Center between November 24, 2023 and November 25, 2025.

Exclusion Criteria:

Patient does not meet registry inclusion criteria.

Study Design

Enrollment

5000 participants

Anticipated

Interventions and Outcome Measures

Arms

Methodist Dallas Medical Center trauma registry

Trauma patients who recieved care at Methodist Dallas Medical Center between November 24, 2023 and November 25, 2025.

Interventions

over- and under-triage rates

To quantify the over- and under-triage rates as relative to trauma activation criteria reform.

Primary outcome measure

  • Determine the over/under-triage rates [ Time Frame: 2 year ]

Central Contacts and Locations

Central contacts

Crystee Cooper, DHEd

214-947-1280ClinicalResearch@mhd.com

Kavya Mankulangara

214-947-4604ClinicalResearch@mhd.com

Locations

Methodist Dallas Medical Center- Clinical Research Institute

Recruiting

Dallas, Texas, United States, 75203

Contacts

Colette Ngo Ndjom

214-947-1289ClinicalResearch@mhd.com

Kavya Mankulangara

214-947-4604ClinicalResearch@mhd.com

More Information

Sponsor

Methodist Health System

Last update posted

Mar 24, 2026

Last verified

Feb, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Methodist Health System on 2026-03-24.